The GBC European investment team are helping to build the next generation of great European companies

The Graybella Capital European investment team has significant experience in global markets & target industries, and have worked together on multiple deals in the US & Europe

The Investment Team

The GrayBella Capital Fund will invest €3-8 (series A & B) over the lifetime of innovative companies in Spain, Portugal, UK & Ireland

Richard P. Kivel

Managing Director

Mario Gobbo

GBC Partner

Gonçalo Amorim

GBC Partner

Dr Milla Marinova


  • CEO, COO & Board Director for public & private companies in the US, Europe & Asia
  • Multiple exits
  • Lecturer on entrepreneurship at MIT & other universities
  • Expertise in building complex businesses in Europe & US
  • Expert on Board Governance as well as venture funding
  • IPO and M&A expertise and experience

  • 15 years of experience in venture projects
  • Founded leading Portugal based Technology Transfer Accelerator
  • Significant experience in building and growing technology companies
  • 8 years medical doctor
  • Clinical research fellow at Imperial College
  • M.Phil. Bioscience Enterprise, Cambridge University & M.Phil. International Health Policy at LSE
The GBC Baltic-Nordic Eight (NB8) Fund will invest €2-5m (series A & B) over the lifetime of innovative companies in the Baltics, Nordics & Eastern Europe.


Ruta Laukien

Managing Partner GBC Nordic-Baltic Eight (NB8)

Sarunas Narbutas

Partner GBC Nordic-Baltic Eight (NB8)

  • 12 years experience in investment banking, private capital raising
  • Multiple IPO’s, capital raises & M&A
  • Business operator with management, strategy & operations experience, with a legal background
  • 10 years experience in Life Sciences policy and regulatory
  • CEO & Board roles for life sciences NGO organisations
  • Top-tier European network of business, academia and public officials